Prognostic value of post-treatment serum soluble interleukin-2 receptor in newly diagnosed diffuse large B-cell lymphoma patients who achieved complete metabolic response following R-CHOP therapy

Patients with DLBCL achieving complete metabolic response (CMR) after initial treatment with R-CHOP generally have a favourable prognosis; however, there are no established prognostic biomarkers for relapse in these patients. Soluble interleukin-2 receptor (sIL-2R) levels at diagnosis are prognostic...

Descripción completa

Detalles Bibliográficos
Autores principales: Shirouchi, Yuko, Nishimura, Noriko, Mishima, Yuko, Ishihara, Yuko, Asai, Hiroaki, Tamba, Mikako, Hirano, Mitsuhito, Hirano, Kei, Teramoto, Yukako, Yoshida, Kikuaki, Takeuchi, Kengo, Terauchi, Takashi, Maruyama, Dai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444791/
https://www.ncbi.nlm.nih.gov/pubmed/37608029
http://dx.doi.org/10.1038/s41598-023-40026-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10444791/
https://www.ncbi.nlm.nih.gov/pubmed/37608029
http://dx.doi.org/10.1038/s41598-023-40026-7

Ejemplares similares